Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Sarcoma, Synovial 3Mesothelioma 3Sarcoma 2Rhabdoid Tumor 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Solid Tumor 1Mesothelioma, Malignant 1Hepatic Impairment 1Hematologic Neoplasms 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

Thiotepa 2Filgrastim 2tazemetostat 1sodium thiosulfate 1pembrolizumab 1X-Rays 1Topotecan 1Specimen Handling 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 1Carboplatin 1Busulfan 1Bone Marrow Transplantation 1Arsenic Trioxide 1Amifostine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × tazemetostat × Other solid neoplasm × Clear all
NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡